Literature DB >> 22124941

GnRH analogue use in postmenopausal hyperandrogenism: long-term remission.

Maria Gueorguiev, Ashley B Grossman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22124941     DOI: 10.1007/s12020-011-9566-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  5 in total

1.  Long-term suppression of testosterone after treatment with a gonadotropin-releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumor.

Authors:  R B Barnes; D A Ehrmann
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

2.  Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist.

Authors:  Z Efstathiadou; A Tsatsoulis
Journal:  Fertil Steril       Date:  2001-01       Impact factor: 7.329

3.  Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin.

Authors:  Esther S Vollaard; André P van Beek; Frederik A J Verburg; Annemieke Roos; Jolande A Land
Journal:  J Clin Endocrinol Metab       Date:  2011-02-09       Impact factor: 5.958

4.  A testosterone-producing adrenal cortical adenoma in an elderly woman.

Authors:  B A Larson; W P Vanderlaan; H L Judd; D L McCullough
Journal:  J Clin Endocrinol Metab       Date:  1976-05       Impact factor: 5.958

5.  Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?

Authors:  G A Kaltsas; J J Mukherjee; B Kola; A M Isidori; J A Hanson; J E Dacie; R Reznek; J P Monson; A B Grossman
Journal:  Clin Endocrinol (Oxf)       Date:  2003-07       Impact factor: 3.478

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.